Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 21504122)

Published in J Alzheimers Dis on January 01, 2010

Authors

Christoph Laske1, Kateryna Sopova, Christos Gkotsis, Gerhard W Eschweiler, Guido Straten, Meinrad Gawaz, Thomas Leyhe, Konstantinos Stellos

Author Affiliations

1: Department of Psychiatry and Psychotherapy Eberhard-Karls Universität Tübingen, Tübingen, Germany. christoph.laske@med.unituebingen.de

Articles by these authors

Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol (2013) 4.03

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J (2006) 3.21

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med (2004) 3.07

A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med (2002) 2.75

A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med (2003) 2.49

Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry (2009) 2.09

Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med (2006) 1.98

Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost (2003) 1.97

Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation (2003) 1.90

Contact force-controlled zero-fluoroscopy catheter ablation of right-sided and left atrial arrhythmia substrates. Heart Rhythm (2012) 1.90

G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med (2003) 1.77

A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. J Am Coll Cardiol (2012) 1.71

Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol (2011) 1.67

Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol (2011) 1.58

Hyperresponsiveness of platelets in ischemic stroke. Thromb Haemost (2007) 1.57

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation. Pharmacogenomics (2008) 1.52

Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imaging (2009) 1.49

Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation (2003) 1.48

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res (2006) 1.46

Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of CD34+ cells in the ischaemic microcirculation. Eur Heart J (2013) 1.41

Retinal vein occlusion disease and platelet activation: will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future? Thromb Haemost (2007) 1.41

Non-invasive and invasive predictors of paravalvular regurgitation post CoreValve® stent prosthesis implantation in aortic valves. J Interv Cardiol (2014) 1.40

Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation (2006) 1.40

CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging (2013) 1.39

Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation (2007) 1.39

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiol Dis (2008) 1.39

Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol (2007) 1.34

The future of Alzheimer's disease: the next 10 years. Prog Neurobiol (2011) 1.31

Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res (2007) 1.27

Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation (2005) 1.25

[11C]PIB binding in Parkinson's disease dementia. Neuroimage (2007) 1.24

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int J Neuropsychopharmacol (2010) 1.21

Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost (2008) 1.17

Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol (2008) 1.16

Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J (2003) 1.16

New developments in the diagnosis of dementia. Dtsch Arztebl Int (2010) 1.16

Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. Eur Heart J (2008) 1.15

Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci (2005) 1.15

Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res (2005) 1.14

Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB J (2006) 1.14

Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood (2003) 1.13

Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation (2007) 1.11

Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation (2002) 1.10

Platelet interaction with progenitor cells: potential implications for regenerative medicine. Thromb Haemost (2007) 1.09

Radionuclide imaging: a molecular key to the atherosclerotic plaque. J Am Coll Cardiol (2008) 1.08

Poor trail making test performance is directly associated with altered dual task prioritization in the elderly--baseline results from the TREND study. PLoS One (2011) 1.07

Platelet-leukocyte interactions in inflammation and atherothrombosis. Semin Thromb Hemost (2007) 1.07

Identification of a blood-based biomarker panel for classification of Alzheimer's disease. Int J Neuropsychopharmacol (2011) 1.07

Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol (2007) 1.07

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. J Alzheimers Dis (2009) 1.06

Correlation of fat distribution in whole body MRI with generally used anthropometric data. Invest Radiol (2009) 1.05

Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med (2003) 1.03

Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thromb Res (2003) 1.03

Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int J Neuropsychopharmacol (2010) 1.02

Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion. Arterioscler Thromb Vasc Biol (2011) 1.02

Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res (2006) 1.01

Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ Res (2011) 1.01

Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res (2008) 1.01

Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood (2003) 1.01

Methods employed for induction and analysis of experimental myocardial infarction in mice. Cell Physiol Biochem (2011) 1.00

Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy. Thromb Res (2009) 1.00

EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis (2009) 0.99

Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol (2008) 0.99

Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke (2006) 0.99

Platelets and endothelial cells. Semin Thromb Hemost (2007) 0.98

Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation (2011) 0.98

Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. J Biol Chem (2011) 0.98

Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation. Blood (2009) 0.98

Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation. Diabetes Care (2007) 0.97

Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. J Am Soc Nephrol (2011) 0.96

Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin. J Mol Cell Cardiol (2010) 0.96

Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding. Thromb Haemost (2008) 0.94

Impairment of episodic and semantic autobiographical memory in patients with mild cognitive impairment and early Alzheimer's disease. Neuropsychologia (2009) 0.94

Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol (2005) 0.94

Response variability to P2Y12 receptor inhibitors: expectations and reality. JACC Cardiovasc Interv (2013) 0.94

Oxidized LDL-activated platelets induce vascular inflammation. Semin Thromb Hemost (2010) 0.94

Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLoS One (2012) 0.93

Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management. Semin Thromb Hemost (2009) 0.93

Prognostic value of mild-to-moderate pulmonary hypertension in patients with severe aortic valve stenosis undergoing aortic valve replacement. Clin Res Cardiol (2011) 0.93

The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice. Circulation (2012) 0.92

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia. Eur Arch Psychiatry Clin Neurosci (2008) 0.92